Skip to main content

Advertisement

SpringerLink
Log in

Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

It is well known that both gastric and intestinal phenotypic markers are expressed in gastric carcinomas, irrespective of their histological type. In the present study, the associations among phenotypic marker expression of gastric carcinomas, tumor thymidylate synthase (TS) expression, and the chemotherapeutic response to 5-fluorouracil (5-FU) were examined.

Methods

The gastric and intestinal phenotypic marker expression of the tumor was determined by the combination of the expression of human gastric mucin (HGM), MUC6, MUC2, and CD10, and was evaluated in comparison with tumor TS expression in 137 advanced gastric carcinomas in 137 patients (75 with postoperative chemotherapy with 5-FU and 62 without postoperative chemotherapy). Tumors were classified into the gastric- (G-), gastric and intestinal mixed- (GI-), intestinal- (I-), or unclassified- (UC-) phenotype according to the immunopositivity of HGM, MUC6, MUC2, and CD10 stainings. The associations among the gastric and intestinal phenotypic marker expression of the tumor, tumor TS expression, effect of postoperative chemotherapy with 5-FU, and the patient’s prognosis were examined.

Results

Of the 137 gastric carcinomas, 48 (35.0%), 58 (42.3%), 23 (16.8%), and 8 (5.8%)were classified as the G-, GI-, I- and UC-phenotype, respectively. The high TS expression of more than 25% tumor cell positivity was found in 25 (52.1%) of the 48 G-phenotype tumors, 39 (67.2%) of the 58 GI-phenotype tumors, 18 (78.3%) of the 23 I-phenotype tumors, and 4 (50.0%) of the 8 UC-phenotype tumors. The I-phenotype tumors were significantly correlated with the higher rate of the high TS expression as compared with the G-phenotype tumors (P<0.05). Among 48 patients with the G-phenotype tumor, the 5-year survival rate in patients with and without postoperative chemotherapy was 39.7 and 27.8%, respectively. The patients with postoperative chemotherapy had a significantly better prognosis than those without postoperative chemotherapy (P<0.05). Conversely, there were no significant correlations between the presence of postoperative chemotherapy and the patient’s prognosis among patients with GI-, I-, and UC-phenotype tumors.

Conclusions

These results indicate that postoperative chemotherapy with 5-FU could be effective for patients with the G-phenotype tumor, since the incidence of intratumoral expression of TS, the target enzyme of 5-FU, is significantly low in G-phenotype tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a–c.
Fig. 2a–c.
Fig. 3.
Fig. 4.
Fig. 5.

Similar content being viewed by others

References

  • Albarracin CT, Jafri J, Montag AG, Hart J, Kuan SF (2000) Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma. Hum Pathol 31:672–677

    CAS  PubMed  Google Scholar 

  • Bara J, Gautier R, Mouradian P, Decaens C, Daher N (1991) Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis. Int J Cancer 47:304–310

    PubMed  Google Scholar 

  • Bolos C de, Garrido M, Real FX (1995) MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 109:723–734

    PubMed  Google Scholar 

  • Egashira Y, Shimoda T, Ikegami M (1999) Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 49:55–61

    Article  CAS  PubMed  Google Scholar 

  • Endoh Y, Tamura G, Watanabe H, Ajioka Y, Motoyama T (1999) The common 18-base pair deletion at codons 418–423 of the E-cadherin gene undifferentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium. J Pathol 189:201–206

    Article  CAS  PubMed  Google Scholar 

  • Hsu SM, Raine L, Fanger H (1981) Use of avidin–biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    CAS  PubMed  Google Scholar 

  • Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma, 1st English edn. Kanehara and Co., Tokyo

  • Johnston PG, Lenz HJ, Leichman CG, Dananberg KD, Allegra CJ, Danenberg PV, Leichman L (1995) Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55:1407–1412

    CAS  PubMed  Google Scholar 

  • Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481

    Google Scholar 

  • Kim YS, Gum JR (1995) Diversity of mucin genes, structure, function, and expression. Gastroenterology 109:999–1013

    CAS  PubMed  Google Scholar 

  • Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K (2000) Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 89:724–732

    Article  CAS  PubMed  Google Scholar 

  • Kuniyasu T, Nakamura T, Tabuchi Y, Kuroda Y (1998) Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness. Cancer 83:1300–1306

    Article  CAS  PubMed  Google Scholar 

  • Larsson PA, Carlson G, Gustavsson B, Spears CP (1996) Thymidylate synthase in advanced gastrointestinal and breast cancers. Acta Oncol 35:469–472

    CAS  PubMed  Google Scholar 

  • Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:31–49

    CAS  Google Scholar 

  • Maehara K, Okuyama T, Oshiro T, Baba H, Anai H, Akazawa K, Sugimachi K (1993) Early carcinoma of the stomach. Surg Gynecol Obstet 177:593–597

    CAS  PubMed  Google Scholar 

  • Nakamura K, Sugano H, Takagi K (1968) Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. GANN 59:251–258

    CAS  PubMed  Google Scholar 

  • Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukura A, Enjoji M (1992) Pathology and prognosis of gastric carcinoma: findings in 10,000 patients who underwent primary gastrectomy. Cancer 70:1030–1037

    CAS  PubMed  Google Scholar 

  • Okabe K, Tsujimoto H, Fukushima M (1997) Preoperation of the antibodies against recombinant human thymidylate synthase for the detection of its intratumoral levels and the application to sensitivity-study of 5-fuorouracil. Oncol Rep 4:685–690

    CAS  Google Scholar 

  • Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: Analysis and examples. Br J Cancer 35:1–39

    CAS  PubMed  Google Scholar 

  • Pinedo HM, Peters GFJ (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6:1653–1664

    CAS  PubMed  Google Scholar 

  • Preusser P, Achtterrath W, Wilke H, Lenaz L, Fink U, Heinicke A, Meyer J, Bunte H (1988) Chemotherapy of gastric cancer. Cancer Treat Rev 15:257–277

    CAS  PubMed  Google Scholar 

  • Reis CA, David L, Correa P, Carneiro F, Bolos C de, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M (1995) Intestinal metaplasia of human stomach displays distinct pattern of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59:1003–1007

    Google Scholar 

  • Ronco P, Allegri L, Melcion C, Pirotsky E, Appay MD, Bariety J, Pontillon F, Verroust P (1984) A monoclonal antibody to brush border and passive nephritis. Clin Exp Immunol 55:319–332

    CAS  PubMed  Google Scholar 

  • Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G (2000) Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 51:165–171

    Article  Google Scholar 

  • Sakamoto H, Yonezawa S, Utsunomiya T, Tanaka S, Kim YS, Sato E (1997) Mucin antigen expression in gastric carcinomas of young and old adults. Hum Pathol 28:1056–1065

    CAS  PubMed  Google Scholar 

  • Sasaki I, Yao T, Nawata H, Tsuneyoshi M (1999) Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development. Cancer 85:1719–1729

    Article  CAS  PubMed  Google Scholar 

  • Shi SR, Key ME, Karla KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741–748

    CAS  PubMed  Google Scholar 

  • Tajima Y, Nakanishi Y, Yoshino T, Kokawa A, Kusano M, Shimoda T (2001a) Clinicopathological study of early adenocarcinoma of the gastric cardia: Comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology 61:1–9

    Article  CAS  Google Scholar 

  • Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K (2001b) Gastric and intestinal phenotypic marker expression in gastric carcinomas and their prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 61:212–220

    Article  CAS  PubMed  Google Scholar 

  • Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N (1990) Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 40:494–504

    CAS  PubMed  Google Scholar 

  • Trejdosiewicz LK, Malizia G, Oakes J, Losowsky MS, Janossy G (1985) Expression of common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol 38:1002–1006

    CAS  PubMed  Google Scholar 

  • Triest BV, Peters GJ (1999) Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer. Oncology 57:179–194

    Article  Google Scholar 

  • Yamachika T, Inada K, Fijimitsu Y, Nakamura S, Yamamura Y, Kitou T, Itzkowitz SH, Werther JL, Miki K, Tatematsu M (1997) Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 431:103–110

    Article  CAS  PubMed  Google Scholar 

  • Yeh KH, Shun CT, Chen CL, Lin JT, Lee WJ, Lee PH, Chen YC, Cheng AL (1998) High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy. Cancer 82:1626–1631

    Article  CAS  PubMed  Google Scholar 

  • Yoshino T, Shimoda T, Saito A, Nakanishi Y, Tajima Y, Shirasu T, Miura S (1999) Macroscopic features of differentiated adenocarcinoma with gastric or intestinal phenotype expression in early gastric cancer. Stomach Intestine 34:513–525 (in Japanese with English abstract)

    Google Scholar 

Download references

Acknowledgement. The authors thank N. Ide and N. Nishino for their excellent technical assistance.

Author information

Authors and Affiliations

  1. Department of Surgery, Toyosu Hospital, Showa University, 1–18, Toyosu 4 chome, Koto-ku, 135-8577, Tokyo, Japan

    Yusuke Tajima, Noboru Yokoyama, Takayuki Tanaka, Kouji Shimizu, Toyohiko Saito & Kazuhide Kumagai

  2. Second Department of Surgery, Faculty of Medicine, Toyosu Hospital, Showa University, 1–18, Toyosu 4 chome, Koto-ku, 135-8577J, Tokyo, Japan

    Yusuke Tajima, Noboru Yokoyama, Masatoshi Kawamura & Mitsuo Kusano

  3. Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan

    Tadakazu Shimoda

  4. Division of Pathology, National Cancer Center Research Institute, Tokyo, Japan

    Yukihiro Nakanishi

Authors
  1. Yusuke Tajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadakazu Shimoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yukihiro Nakanishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noboru Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takayuki Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kouji Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Toyohiko Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masatoshi Kawamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mitsuo Kusano
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kazuhide Kumagai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhide Kumagai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tajima, Y., Shimoda, T., Nakanishi, Y. et al. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil. J Cancer Res Clin Oncol 129, 683–690 (2003). https://doi.org/10.1007/s00432-003-0476-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-003-0476-0

Keywords

Search

Navigation